Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pre-clinical evaluation of the efficacy and safety of human induced pluripotent stem cell-derived cardiomyocyte patch

12 Mar 2024

Abstract excerpt

BACKGROUND: Cell- or tissue-based regenerative therapy is an attractive approach to treat heart failure. A tissue patch that can safely and effectively repair damaged heart muscle would greatly improve outcomes for patients with heart failure. In this study, we conducted a preclinical proof-of-concept analysis of the efficacy and safety of clinical-grade human induced pluripotent stem cell-derived cardiomyocyte...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mesenchymal stem cell research
Share to Pluripotent Stem Cells Research
Share to Tissue Engineering and Regenerative Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38475911
DOI: 10.1186/s13287-024-03690-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pre-clinical evaluation of the efficacy and safety of human induced pluripotent stem cell-derived cardiomyocyte patchPMID 38475911Read ↗

Evaluation of the Efficacy and Safety of a Clinical Grade Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Patch: A Pre-Clinical StudySemantic proximity Read ↗

Transplantation of IPSC-Derived Cardiomyocyte Patches for Ischemic CardiomyopathySemantic proximity Read ↗

Induced Pluripotent Stem Cells Technology and Cardiomyocyte Generation: Progress, Uncertainties and Challenges in the Biological Features and Clinical ApplicationsSemantic proximity Read ↗

Multicellular Human Cardiac Organoids Transcriptomically Model Distinct Tissue-Level Features of Adult MyocardiumSemantic proximity Read ↗

Human Induced Pluripotent Stem Cells as a Disease Model System for Heart FailureSemantic proximity Read ↗

Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug DiscoverySemantic proximity Read ↗

Human Engineered Heart Tissue Models for Disease Modeling and Drug DiscoverySemantic proximity Read ↗

Heart regeneration with human pluripotent stem cells: Prospects and challengesSemantic proximity Read ↗

Cardiac tissue engineering: Multiple approaches and potential applicationsSemantic proximity Read ↗

Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived Cardiomyocytes.Semantic proximity Read ↗

Effective Cardiac Myocyte Differentiation of Human Induced Pluripotent Stem Cells Requires VEGFSemantic proximity Read ↗

Cardiac Regeneration with Human Pluripotent Stem Cell-Derived CardiomyocytesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.